Atara Biotherapeutics, Inc.
ATRA
$14.10
$1.5512.35%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -79.59% | -36.75% | -70.07% | -17.84% | -34.39% |
| Total Receivables | 43.30% | -- | -75.37% | -95.65% | 137.12% |
| Inventory | -- | -- | -- | 9.78% | 112.11% |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -69.98% | -58.82% | -44.71% | 62.10% | 2.38% |
| Total Current Assets | -79.93% | -60.31% | -74.46% | -36.30% | -22.61% |
|
|
|||||
| Total Current Assets | -79.93% | -60.31% | -74.46% | -36.30% | -22.61% |
| Net Property, Plant & Equipment | -77.15% | -78.15% | -41.76% | -30.09% | -25.56% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -73.76% | -74.31% | -26.47% | -35.94% | -46.62% |
| Total Assets | -78.86% | -68.54% | -62.46% | -34.08% | -24.41% |
|
|
|||||
| Total Accounts Payable | -85.18% | -66.46% | -51.51% | 18.54% | -67.04% |
| Total Accrued Expenses | -77.64% | -58.23% | -59.14% | -56.32% | -52.11% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -86.68% | -83.98% | -0.83% | 14.27% | 10.24% |
| Total Finance Division Other Current Liabilities | -90.82% | -98.51% | -87.02% | 22.17% | 902.02% |
| Total Other Current Liabilities | -90.82% | -98.51% | -87.02% | 22.17% | 902.02% |
| Total Current Liabilities | -88.42% | -90.18% | -73.49% | -5.38% | 97.22% |
|
|
|||||
| Total Current Liabilities | -88.42% | -90.18% | -73.49% | -5.38% | 97.22% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -57.42% | -60.14% | -33.58% | -31.03% | -27.35% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -19.71% | 1.87% | 1.23% | -47.55% | -62.49% |
| Total Liabilities | -71.36% | -68.47% | -55.57% | -22.04% | -2.66% |
|
|
|||||
| Common Stock & APIC | 1.56% | 3.67% | 3.09% | 4.66% | 5.00% |
| Retained Earnings | 1.15% | 0.29% | -0.78% | -4.34% | -6.98% |
| Treasury Stock & Other | -90.91% | -- | -- | 103.92% | 103.85% |
| Total Common Equity | 59.54% | 68.39% | 43.98% | 1.96% | -78.09% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 59.54% | 68.39% | 43.98% | 1.96% | -78.09% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 59.54% | 68.39% | 43.98% | 1.96% | -78.09% |
|
|
|||||